Why the study?
What are the pathogenic mechanisms leading to poor prognosis in diabetic patients after acute myocardial infarction, and are current interventions effective?
Population
Diabetic patients who have had acute myocardial infarction
Comparison
Current therapies for myocardial infarction vs Nondiabetic patients (for mortality comparison)
Design
Review
Authors
Loading...
Persistent excess post-MI mortality in diabetes warrants targeted strategies; leaves open whether novel interventions can narrow the gap.
What are the pathogenic mechanisms leading to poor prognosis in diabetic patients after acute myocardial infarction, and are current interventions effective?
Diabetic patients experience 1.5 to 2 times higher mortality after acute myocardial infarction compared to nondiabetics, driven by heart failure and reinfarction, though standard MI therapies remain effective.
Doron Aronson (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: